A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer

Radiation Oncology

Matthias Eiber¹  Michal Devecka²  Eva K. Sage²  Kilian Schiller²  Sabrina Dewes²  Marco M. E. Vogel³  Stephanie E. Combs⁴  Jürgen E. Gschwend⁵ 

[1] Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany;Department of Radiation Oncology, Klinikum rechts der isar, Technical University of Munich (TUM), Ismaninger Strasse 22, 81675, Munich, Germany;Department of Radiation Oncology, Klinikum rechts der isar, Technical University of Munich (TUM), Ismaninger Strasse 22, 81675, Munich, Germany;Department of Radiation Sciences (DRS), Institute for Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany;Department of Radiation Oncology, Klinikum rechts der isar, Technical University of Munich (TUM), Ismaninger Strasse 22, 81675, Munich, Germany;Department of Radiation Sciences (DRS), Institute for Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany;Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany;Department of Urology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany;

关键词: PSMA-PET;    Prostate cancer;    Radiotherapy;    Survey;   

DOI  :  10.1186/s13014-021-01811-8

来源: Springer

【 授权许可】

CC BY